RAB5A and colorectal carcinoma: In-depth studies found that upregulated expression of ALKBH5 can lead to stability enhancement of RAB5A, which impedes YTHDF2-mediated RAB5A mRNA decay and increases RAB5A expression, ultimately influencing the tumorigenicity of CRC (65).